Literature DB >> 11069947

Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases.

Y Hashimoto1, H Jiang, T Niikura, Y Ito, A Hagiwara, K Umezawa, Y Abe, Y Murayama, I Nishimoto.   

Abstract

The epsilon4 genotype of apolipoprotein E (apoE4) is the most established predisposing factor in Alzheimer's disease (AD); however, it remains unclear how apoE4 contributes to the pathophysiology. Here, we report that the apoE4 protein (ApoE4) evokes apoptosis in neuronal cells through the low-density lipoprotein receptor-related protein (LRP) and heterotrimeric GTPases. We examined neuron/neuroblastoma hybrid F11 cells and found that these cells were killed by 30 microg/ml ApoE4, but not by 30 microg/ml ApoE3. ApoE4-induced death occurred with typical features for apoptosis in time- and dose-dependent manners, and was observed in SH-SY5Y neuroblastomas, but not in glioblastomas or non-neuronal Chinese hamster ovary cells. Activated, but not native, alpha2-macroglobulin suppressed this ApoE4 toxicity. Suppression by the antisense oligonucleotide to LRP and inhibition by low nanomolar concentrations of LRP-associated protein RAP provided evidence for the involvement of LRP. The involvement of heterotrimeric GTPases was demonstrated by the findings that (1) ApoE4-induced death was suppressed by pertussis toxin (PTX), but not by heat-inactivated PTX; and (2) transfection with PTX-resistant mutant cDNAs of Galpha(i) restored the toxicity of ApoE4 restricted by PTX. We thus conclude that one of the neurotoxic mechanisms triggered by ApoE4 is to activate a cell type-specific apoptogenic program involving LRP and the G(i) class of GTPases and that the apoE4 gene may play a direct role in the pathogenesis of AD and other forms of dementia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069947      PMCID: PMC6773153     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  97 in total

1.  Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide.

Authors:  K L Moulder; M Narita; L K Chang; G Bu; E M Johnson
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

2.  Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells.

Authors:  D Platika; M H Boulos; L Baizer; M C Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.

Authors:  J S Whitson; M P Mims; W J Strittmatter; T Yamaki; J D Morrisett; S H Appel
Journal:  Biochem Biophys Res Commun       Date:  1994-02-28       Impact factor: 3.575

4.  A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic.

Authors:  R B DeMattos; F E Thorngate; D L Williams
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

5.  Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate.

Authors:  Y Murayama; T Okamoto; E Ogata; T Asano; T Iiri; T Katada; M Ui; J H Grubb; W S Sly; I Nishimoto
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

6.  Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.

Authors:  S Helisalmi; K Linnaranta; M Lehtovirta; A Mannermaa; O Heinonen; M Ryynänen; P Riekkinen; H Soininen
Journal:  Neurosci Lett       Date:  1996-02-16       Impact factor: 3.046

7.  Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease.

Authors:  T Okamoto; S Takeda; U Giambarella; Y Murayama; T Matsui; T Katada; Y Matsuura; I Nishimoto
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

8.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells.

Authors:  M B Lopes; C A Bogaev; S L Gonias; S R VandenBerg
Journal:  FEBS Lett       Date:  1994-02-07       Impact factor: 4.124

9.  Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of G alpha i2. A novel implication of retinoblastoma gene product.

Authors:  T Ikezu; T Okamoto; Y Murayama; T Okamoto; Y Homma; E Ogata; I Nishimoto
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

10.  In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor.

Authors:  T Ikezu; T Okamoto; U Giambarella; T Yokota; I Nishimoto
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  19 in total

1.  A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.

Authors:  Y Hashimoto; T Niikura; H Tajima; T Yasukawa; H Sudo; Y Ito; Y Kita; M Kawasumi; K Kouyama; M Doyu; G Sobue; T Koide; S Tsuji; J Lang; K Kurokawa; I Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 2.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

3.  Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.

Authors:  Enkhzol Malchinkhuu; Koichi Sato; Takeshi Muraki; Koichi Ishikawa; Atsushi Kuwabara; Fumikazu Okajima
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

4.  Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner.

Authors:  T Niikura; Y Hashimoto; T Okamoto; Y Abe; T Yasukawa; M Kawasumi; T Hiraki; Y Kita; K Terashita; K Kouyama; I Nishimoto
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

5.  Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction.

Authors:  Samuel O Adeosun; Xu Hou; Baoying Zheng; Craig Stockmeier; Xiaoming Ou; Ian Paul; Thomas Mosley; Karl Weisgraber; Jun Ming Wang
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

6.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

Review 7.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.

Authors:  ZhiHua Shi; Marcelo Rudzinski; Karen Meerovitch; Frédéric Lebrun-Julien; Elena Birman; Adriana Di Polo; H Uri Saragovi
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

10.  Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.

Authors:  Thomas Tousseyn; Krystyna Bajsarowicz; Henry Sánchez; Ania Gheyara; Abby Oehler; Michael Geschwind; Bernadette DeArmond; Stephen J DeArmond
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.